Otero Jose Manuel 4
4 · Lexeo Therapeutics, Inc. · Filed Apr 9, 2025
Insider Transaction Report
Form 4
Otero Jose Manuel
Chief Operating Officer
Transactions
- Award
Common Stock
2025-03-14$2.61/sh+5,720$14,929→ 63,220 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]Includes 57,500 restricted stock units.